Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-01

FDA Approved: TALICIA — Original Application (RedHill Biopharma Ltd)

View source ↗

Summary

FDA approved TALICIA, a fixed-dose combination of omeprazole magnesium, amoxicillin, and rifabutin, for Helicobacter pylori infection. The approval was granted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TALICIA (Omeprazole magnesium, amoxicillin and rifabutin)

Snippet

ORIG AP for TALICIA (OMEPRAZOLE MAGNESIUM, AMOXICILLIN AND RIFABUTIN)